Year-end Sale % OFF 
Abstract
Abstract— A new CNS myelin autoantigen(s) (referred to as M2), different from the encephalitogenic basic protein (BP), can be detected with guinea‐pig demyelinating and complement fixing (CF) sera raised against guinea pig CNS tissue or myelin (Lebaret al., 1976). M2 and BP were present in mouse, rat, rabbit, bovine and human CNS tissues when tested with guinea‐pig homologous specific antisera; they were not present in non‐CNS tissues. Both autoantigens were also detected in newborn guinea‐pig myelin and myelin‐like fractions.The CF activity of myelin with demyelinating (anti‐M2) sera was not altered by trypsin; however, absorption experiments showed that M2 was partly trypsin sensitive. Both antibodies against the trypsin sensitive and the trypsin resistant determinants of M2 were demyelinating. Both determinants of M2 were preselit in mouse, rat, rabbit, bovine‘and human CNS tissues and in guinea‐pig newborn myelin. CF BP activity of myelin was partially or even totally abolished by trypsin, but the persistent encephali‐togenicity of trypsin‐treated myelin could be attributed to non‐CF encephalitogenic peptides from BP.In accordance with recent work our results tend to support an inner localization of BP in myelin; M2, on the other hand, would be a surface antigen(s).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
